Knowledge Translation in OncologyThe Bumpy Ride From Bench to Bedside

被引:7
|
作者
Morgan, Sarah [1 ,2 ]
Hanna, Jessica [1 ,2 ]
Yousef, George M. [1 ,2 ]
机构
[1] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada
[2] Hosp Sick Children, Dept Paediat Lab Med, Toronto, ON, Canada
关键词
Knowledge translation; Precision medicine; Molecular pathology; Personalized medicine; PRIMARY-CARE; GENOMIC MEDICINE; DECISION-SUPPORT; GENETIC SERVICES; RISK-ASSESSMENT; CANCER; INTEGRATION; PHYSICIANS;
D O I
10.1093/ajcp/aqz099
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Objectives: Knowledge translation (KT) is the dynamic process of mobilizing best-practice evidence to guide health care decisions. Methods: Using a PubMed search, challenges were identified and milestones defined. Results: Substantial challenges exist in integrating discoveries into patient care, including technical limitations related to genomic testing like turnaround time, standardization, reproducibility, and results interpretation. Other challenges include lack of proper training in genetic counseling for health care providers, clarity of scientific evidence, and ethical, legal and social considerations. In addition, most health care systems lack accessibility to genetic testing services. Moving forward, KT should be addressed at three main frontiers. The first is patients centered for proper understanding and decision making; the second is directed toward health care professionals, including clinical decision support and clarity of roles; and the third addresses resources of health care systems. Conclusions: Implementing KT requires developing strategies to enhance awareness and promote behavioral changes congruent with research evidence, designing a systematic approach by health care providers and stakeholders to achieve patient-centered care.
引用
收藏
页码:5 / 13
页数:9
相关论文
共 50 条
  • [21] miR-34: from bench to bedside
    Agostini, Massimiliano
    Knight, Richard A.
    ONCOTARGET, 2014, 5 (04) : 872 - 881
  • [22] The role of collagen in cancer: from bench to bedside
    Xu, Shuaishuai
    Xu, Huaxiang
    Wang, Wenquan
    Li, Shuo
    Li, Hao
    Li, Tianjiao
    Zhang, Wuhu
    Yu, Xianjun
    Liu, Liang
    JOURNAL OF TRANSLATIONAL MEDICINE, 2019, 17 (01)
  • [23] Regulatory T cells: From bench to bedside
    Jiang, Shuiping
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2009, 9 (05) : 515 - 517
  • [24] Dendritic cells from bench to bedside and back
    Adema, G. J.
    IMMUNOLOGY LETTERS, 2009, 122 (02) : 128 - 130
  • [25] Oncofertility: Treatment options from bench to bedside
    Gupta, Divya
    Singh, Shubham
    Shukla, Sangeeta
    Shrivastava, Sadhana
    CANCER PATHOGENESIS AND THERAPY, 2023, 1 (04): : 284 - 289
  • [26] Coronary atherosclerosis and chemotherapy: From bench to bedside
    Zhou, Fanghui
    Zhu, Xinxin
    Liu, Yao
    Sun, Yue
    Zhang, Ying
    Cheng, Dechun
    Wang, Wei
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2023, 10
  • [27] Editorial: Sarcoidosis and autoimmunity: From bench to bedside
    d'Alessandro, Miriana
    FRONTIERS IN MEDICINE, 2023, 10
  • [28] Liquid biopsy-from bench to bedside
    Ray, Amitava
    Vohra, Tarang K.
    NEURO-ONCOLOGY ADVANCES, 2022, 4 : 66 - 72
  • [29] Targeted Radiotherapeutics from 'Bench-to-Bedside'
    Muller, Cristina
    Behe, Martin
    Geistlich, Susanne
    van der Meulen, Nicholas P.
    Schibli, Roger
    CHIMIA, 2020, 74 (12) : 939 - 945
  • [30] Clinical and Translational Science: From Bench-Bedside to Global Village
    Waldman, Scott A.
    Terzic, Andre
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2010, 3 (05): : 254 - 257